WuXi Biologics and Earendil Labs collaborate to accelerate development and manufacturing of bispecific/multispecific antibodies and ADCs, enhancing complex biologics capabilities.
The partnership strengthens WuXi Biologics’ position in the growing bispecific/multispecific antibody and ADC markets, enabling faster time-to-market and expanded service offerings in complex biologics manufacturing.
Strategic collaboration targets bispecific/multispecific antibodies and ADCs development and manufacturing
Combines expertise to accelerate innovation and production efficiency
Enhances WuXi Biologics’ capabilities in complex biologics
Enhances WuXi Biologics’ capabilities in complex biologics
Supports faster time-to-market for advanced therapeutics
Sign in to save notes on signals.
Sign In